A Multicenter, Randomized, Double-blind, Placebo-controlled Study With an Open-label Run-in to Assess the Efficacy and Safety of Hydrocodone Bitartrate (HYD) Tablets 20 to 120 mg Once-daily in Subjects With Moderate to Severe Chronic Low Back Pain.
Phase of Trial: Phase III
Latest Information Update: 02 Apr 2018
At a glance
- Drugs Hydrocodone (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors Purdue Pharma
- 12 Mar 2014 Results reported in a Purdue Pharma media release.
- 01 Oct 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Sep 2013 Planned End Date changed from 1 Nov 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History